Log in to your Inderes Free account to see all free content on this page.
Demant
213.40 DKK
+0.85 %
Less than 1K followers
DEMANT
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Demant
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 14,946.0 | 14,469.0 | 18,388.0 | 19,705.0 | 22,443.0 | 22,419.0 | 22,971.0 |
| growth-% | -3.2 % | 27.1 % | 7.2 % | 13.9 % | -0.1 % | 2.5 % | |
| EBITDA | 3,075.0 | 2,541.0 | 4,479.0 | 4,383.0 | 5,482.0 | 5,761.0 | 5,351.0 |
| EBIT | 2,151.0 | 1,530.0 | 3,445.0 | 3,207.0 | 4,148.0 | 4,528.0 | 3,832.0 |
| Profit before taxes | 1,911.0 | 1,336.0 | 3,243.0 | 2,927.0 | 3,394.0 | 3,716.0 | 3,101.0 |
| Net income | 1,467.0 | 1,134.0 | 2,528.0 | 2,084.0 | 1,798.0 | 2,388.0 | 1,544.0 |
| EPS | 5.98 | 4.59 | 10.28 | 9.21 | 8.04 | 10.99 | 7.31 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | 20.6 % | 17.6 % | 24.4 % | 22.2 % | 24.4 % | 25.7 % | 23.3 % |
| EBIT-% | 14.4 % | 10.6 % | 18.7 % | 16.3 % | 18.5 % | 20.2 % | 16.7 % |
| ROE | 19.2 % | 13.7 % | 31.7 % | 24.3 % | 19.3 % | 24.8 % | 15.6 % |
| ROI | 6.7 % | 5.2 % | 10.2 % | 7.0 % | 5.9 % | 7.4 % | 4.0 % |
Login required
This content is only available for logged in users